Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserving radiotherapy.

Xiong Y, Shan J, Liu J, Zhao K, Chen S, Xu W, Zhou Q, Yang M, Lei X.

Sci Rep. 2017 Jan 17;7:40619. doi: 10.1038/srep40619.

2.

A prognostic model for advanced colorectal neoplasia recurrence.

Liu L, Messer K, Baron JA, Lieberman DA, Jacobs ET, Cross AJ, Murphy G, Martinez ME, Gupta S.

Cancer Causes Control. 2016 Oct;27(10):1175-85. doi: 10.1007/s10552-016-0795-5. Epub 2016 Aug 12.

3.

Optimal Colonoscopy Surveillance Interval after Polypectomy.

Kim TO.

Clin Endosc. 2016 Jul;49(4):359-63. doi: 10.5946/ce.2016.080. Epub 2016 Jul 29. Review.

4.

Development and validation of a risk score for advanced colorectal adenoma recurrence after endoscopic resection.

Facciorusso A, Di Maso M, Serviddio G, Vendemiale G, Muscatiello N.

World J Gastroenterol. 2016 Jul 14;22(26):6049-56. doi: 10.3748/wjg.v22.i26.6049.

5.

Rate and Risk Factors of the Advanced Adenomas Among Diminutive Colorectal Polyps.

Aktekin A, Comunoglu N, Odabasi M, Muftuoglu T, Gurleyik G, Abanonu GB.

Indian J Surg. 2015 Dec;77(Suppl 3):805-10. doi: 10.1007/s12262-013-1006-1. Epub 2013 Nov 13.

6.

Associations between tumor markers and the risk of colorectal polyp recurrence in Chinese people.

Tong J, Wang Y, Chang B, Zhang D, Wang B.

Int J Clin Exp Med. 2015 Apr 15;8(4):6397-405. eCollection 2015.

7.
8.

Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis.

Zhou D, Yang L, Zheng L, Ge W, Li D, Zhang Y, Hu X, Gao Z, Xu J, Huang Y, Hu H, Zhang H, Zhang H, Liu M, Yang H, Zheng L, Zheng S.

PLoS One. 2013;8(1):e53310. doi: 10.1371/journal.pone.0053310. Epub 2013 Jan 2.

9.

Korean guidelines for postpolypectomy colonoscopy surveillance.

Yang DH, Hong SN, Kim YH, Hong SP, Shin SJ, Kim SE, Lee BI, Lee SH, Park DI, Kim HS, Yang SK, Kim HJ, Kim SH, Kim HJ; Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening, Surveillance and Management.

Clin Endosc. 2012 Mar;45(1):44-61. doi: 10.5946/ce.2012.45.1.44. Epub 2012 Mar 31.

10.

AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.

Lakis S, Papamitsou T, Panagiotopoulou C, Kotakidou R, Kotoula V.

World J Gastroenterol. 2010 May 28;16(20):2476-83.

11.

Polyp surveillance.

Buie WD, MacLean AR.

Clin Colon Rectal Surg. 2008 Nov;21(4):237-46. doi: 10.1055/s-0028-1089938.

12.

Endoscopic and histopathologic predictors of recurrence of colorectal adenoma on lowering the miss rate.

Ji JS, Choi KY, Lee WC, Lee BI, Park SH, Choi H, Kim BW, Chae HS, Park YM, Park YJ.

Korean J Intern Med. 2009 Sep;24(3):196-202. doi: 10.3904/kjim.2009.24.3.196. Epub 2009 Aug 26.

13.

A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER.

Gastroenterology. 2009 Mar;136(3):832-41. doi: 10.1053/j.gastro.2008.12.007. Epub 2008 Dec 9.

14.

Non-compliance in surveillance for patients with previous resection of large (> or = 1 cm) colorectal adenomas.

Brueckl WM, Fritsche B, Seifert B, Boxberger F, Albrecht H, Croner RS, Wein A, Hahn EG.

World J Gastroenterol. 2006 Dec 7;12(45):7313-8.

15.

Reduction of the incidence and mortality of rectal cancer by polypectomy: a prospective cohort study in Haining County.

Zheng S, Liu XY, Ding KF, Wang LB, Qiu PL, Ding XF, Shen YZ, Shen GF, Sun QR, Li WD, Dong Q, Zhang SZ.

World J Gastroenterol. 2002 Jun;8(3):488-92.

Supplemental Content

Support Center